Inventor · disambiguated record
Sivanesan Dakshanamurthy
Also filed as: DAKSHANAMURTHY SIVANESAN
15 granted patents·8 pending applications·24 citations·filing 2007–2021
87Inventor score
Files withUNIV GEORGETOWN8UNIV HOWARD6UNIV NOVA SOUTHEASTERN3BYERS STEPHEN W2DAKSHANAMURTHY SIVANESAN1
Top patents by PatentIndex Score
23 records- 0186US7875603B2Specific inhibitors for vascular endothelial growth factor receptorsUNIV NOVA SOUTHEASTERN·Filed 2007·Granted Jan 25, 2011·16 cites·6 claims
- 0281US11596623B2Methods for treating virus infection or proliferationUNIV HOWARD·Filed 2019·Granted Mar 7, 2023·2 cites·11 claims
- 0373US11576901B2Methods for treating viral infectionUNIV HOWARD·Filed 2017·Granted Feb 14, 2023·1 cites·12 claims
- 0473US11373734B2Methods and systems for populating and searching a drug informatics databaseUNIV GEORGETOWN·Filed 2013·Granted Jun 28, 2022·1 cites·15 claims
- 0570US9889131B2Cadherin-11 inhibitors and methods of use thereofUNIV GEORGETOWN·Filed 2016·Granted Feb 13, 2018·1 cites·11 claims
- 0670US8802687B2Cadherin-11 inhibitors and methods of use thereofBYERS STEPHEN W·Filed 2010·Granted Aug 12, 2014·2 cites·3 claims
- 0769US9284368B2Substituted pyrazines as cadherin-11 inhibitorsUNIV GEORGETOWN·Filed 2014·Granted Mar 15, 2016·1 cites·8 claims
- 0863US11737462B2Methods for modulating plant response to environmentally-induced stressUNIV HOWARD·Filed 2018·Granted Aug 29, 2023·0 cites·12 claims
- 0959US7939557B2Vascular endothelial receptor specific inhibitorsUNIV NOVA SOUTHEASTERN·Filed 2007·Granted May 10, 2011·0 cites·1 claims
- 1055US2023210849A1Cadherin-11 inhibitor formulation and its uses in immunotherapyUNIV GEORGETOWN·Filed 2021·Application pending·0 cites
- 1155US2015119250A1Methods for modulating plant response to environmentally-induced stressUNIV HOWARD·Filed 2013·Application pending·0 cites
- 1252US10806725B2Small molecule inhibitors of XBP1 splicingUNIV GEORGETOWN·Filed 2016·Granted Oct 20, 2020·0 cites·16 claims
- 1349US2011086868A1Specific inhibitors for vascular endothelial growth factor receptorsUNIV NOVA SOUTHEASTERN·Filed 2010·Application pending·0 cites
- 1447US11179395B2Treating melanoma with mebendazole and a mitogen-activated kinase inhibitorUNIV GEORGETOWN·Filed 2018·Granted Nov 23, 2021·0 cites·4 claims
- 1547US10916331B2Predicting drug-target interactions and uses for drug repositioning and repurposingUNIV GEORGETOWN·Filed 2016·Granted Feb 9, 2021·0 cites·17 claims
- 1647US10301265B2Small molecule inhibitors of botulinum neurotoxinsROXAS DUNCAN VIRGINIA I·Filed 2009·Granted May 28, 2019·0 cites·6 claims
- 1747US9359299B2Small molecules for treating breast cancerDAKSHANAMURTHY SIVANESAN·Filed 2012·Granted Jun 7, 2016·0 cites·27 claims
- 1846US2022211673A1Methods for treating against virusesUNIV HOWARD·Filed 2020·Application pending·0 cites
- 1946US2022168277A1Drug inhibitor against migration and invasion of cancer cells and methods of treating against metastasis of cancer cellsUNIV HOWARD·Filed 2020·Application pending·0 cites
- 2044US2019117869A1Apparatus and methods to remove toxins from blood by plasmapheresisDD INNOVATIONS LAB LLC·Filed 2018·Application pending·0 cites
- 2144US2015324546A1Method for predicting drug-target interactions and uses for drug repositioningUNIV GEORGETOWN·Filed 2013·Application pending·0 cites
- 2243US9199918B2Small molecule inhibitors of AGBL2BYERS STEPHEN W·Filed 2012·Granted Dec 1, 2015·0 cites·6 claims
- 2339US2019256471A1Small molecule inhibitors of botulinum neurotoxinsTHE GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AR·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →